Chargement de la fiche…
Chargement de la fiche…
MonRhumato.fr utilise des cookies pour mesurer l'audience (statistiques) et améliorer le site. Aucune donnée de santé identifiable n'est jamais collectée. Politique de confidentialité.
Votre choix est conservé 13 mois (durée max CNIL). Vous pouvez le modifier à tout moment via Préférences cookies.
4 raisons identifiées
Plateau technique de référence
Assistance publique – Hôpitaux de Paris (APHP) — équipements et expertise pointus pour les cas complexes
Auteur de référence en rhumatologie
21 articles scientifiques publiés — un praticien à la pointe de la recherche
Encadrant universitaire
Forme la prochaine génération de rhumatologues (6 thèses dirigées)
Délais de RDV courts dans la région
134 rhumatos / 100 000 hab. — département bien doté
✨ Génération du profil synthétique IA en cours…
Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.
Le rôle de la Caséine Kinase 2 dans le cycle de vie du SARS-CoV-2 : implications pour le développement d'antiviraux ciblés sur l'hôte
2025Doctorant·e : Dennis Salomon Lopez molina
Mécanismes d’entrée de SARS-CoV-2 : relation hôte-virus au site de primo-infection et repositionnement thérapeutique
2023Doctorant·e : Margot Morin-Dewaële
Caractérisation de l’activité antivirale d’une nouvelle famille de petites molécules à large spectre antiviral inhibitrices des cyclophilines sur le virus respiratoire syncytial humain et repositionnement de médicaments dans le cadre de la pandémie du SARS-CoV-2
2022Doctorant·e : François Berry
Caractérisation de l'activité anti-zika et anti-coronavirus d'une nouvelle classe de petites molécules à large spectre antiviral, inhibitrices des cyclophilines
2021Doctorant·e : Laurent Softic
Rôle de Programmed cell Death-Ligand 1 dans la progression du carcinome hépatocellulaire
2021Doctorant·e : Benoît Rousseau
Etude de la régulation de l’expression des ARN non-codants au cours de l’infection par des virus à ARN : Implications de la protéine KSRP dans la réplication du virus de l’Hépatite C et de la souche HCoV-229E des Coronavirus
2019Doctorant·e : Camille Baudesson
Source theses.fr — signal de direction d'équipe / statut PU-PH (à confirmer via le site universitaire).
Indicateurs publics agrégés sur 250 M+ d'œuvres scientifiques (OpenAlex, PubMed). Traduits ici en langage patient.
Influence scientifique
100
100 articles ont été cités au moins 100fois par d'autres chercheurs — preuve que ses travaux sont repris par la communauté médicale.
h-index
Total citations reçues
41 502
Nombre de fois où d'autres équipes ont mentionné ses publications dans leurs propres travaux.
Publications totales
902
Articles, revues et chapitres référencés dans les bases académiques internationales.
Articles influents
402
Publications ayant marqué leur domaine — chacune citée au moins 10 fois par d'autres chercheurs.
i10-index
Thématiques principales
Source : OpenAlex (CC0, OurResearch). Indicateurs académiques agrégés sur 250 M+ d'œuvres.
Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.
Prospective multicentre study of upper respiratory mucosal transcriptomics reveals two major endotypes of critically ill COVID-19 patients
2026ArticleCommunications Medicine
Clinical Phenotypes of Critically Ill Patients with COVID-19 Infected with Omicron: A Nationwide Prospective Cohort Study
2026ArticleInfectious Diseases and Therapy
Impaired serum neutralization and death in Omicron-infected critically ill patients: insights from the French SEVARVIR prospective, multicenter cohort study
2025ArticleIntensive Care Medicine Experimental
Effect of temporary suspension of chronic immunosuppressive drugs on day-90 mortality and ICU-acquired infections among critically Ill patients with solid organ transplant: a retrospective multicenter study
2025ArticleIntensive Care Medicine
Prevalence of thromboembolic events in critically-ill COVID-19 patients infected with Omicron: results from the French prospective, multicenter SEVARVIR cohort study
2025ArticleCritical Care
Picomolar bivalent inhibitors of protein kinase CK2 active against β-coronavirus replication
2025ArticleEuropean Journal of Medicinal Chemistry
Genotypic and phenotypic characterisation of respiratory syncytial virus after nirsevimab breakthrough infections: a large, multicentre, observational, real-world study
2025ArticleThe Lancet Infectious Diseases
Virological markers for clinical trials in chronic viral hepatitis
2024ArticleJHEP Reports Innovation in Hepatology
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
GHU APHP HM SITE HENRI MONDOR
51 AV MAL DE LATTRE DE TASSIGNY, 94010 CRETEIL CEDEX
Secteur de conventionnement non disponible (médecin hospitalier ou non présent dans l'Annuaire santé CNAM des libéraux conventionnés).
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Journal of hepatology · 2023
The Journal of infectious diseases · 2022
Abstract Background Finger-stick point-of-care and dried blood spot (DBS) hepatitis C virus (HCV) RNA testing increases testing uptake and linkage to care. This systematic review evaluated the diagnostic accuracy of point-of-care testing and DBS to detect HCV RNA. Methods Bibliographic databases and conference presentations were searched for eligible studies. Meta-analysis was used to pool estimates. Results Of 359 articles identified, 43 studies were eligible and included. When comparing the Xpert HCV Viral Load Fingerstick assay to venous blood samples (7 studies with 987 samples), the sensitivity and specificity for HCV RNA detection was 99% (95% confidence interval [CI], 97%–99%) and 99% (95% CI, 94%–100%) and for HCV RNA quantification was 100% (95% CI, 93%–100%) and 100% (95% CI, 94%–100%). The proportion of invalid results following Xpert HCV Viral Load Fingerstick testing was 6% (95% CI, 3%–11%). When comparing DBS to venous blood samples (28 studies with 3988 samples) the sensitivity and specificity for HCV RNA detection was 97% (95% CI, 95%–98%) and 100% (95% CI, 98%–100%) and for HCV RNA quantification was 98% (95% CI, 96%–99%) and 100% (95% CI, 95%–100%). Conclusions Excellent diagnostic accuracy was observed across assays for detection of HCV RNA from finger-stick and DBS samples. The proportion of invalid results following Xpert HCV Viral Load Fingerstick testing highlights the importance of operator training and quality assurance programs.
The Journal of infectious diseases · 2024
Abstract Background Respiratory syncytial virus (RSV) infection is gaining interest due to the recent development of vaccines but is still misdiagnosed in the elderly. The primary objective was to compare all-cause mortality at day 30. Secondary objectives were to compare clinical presentation and rates of consolidative pneumonia, hospitalization, and intensive care unit (ICU) admission. Methods A single-center retrospective study was conducted in a French university hospital during 7 epidemic seasons including 558 patients aged ≥75 years: 125 with RSV and 433 with influenza (median age, 84.8 years). Results Patients with RSV had more respiratory symptoms (wheezing, dyspnea) whereas patients with influenza had more general symptoms (fever, asthenia, myalgia). The following were higher in the RSV group: consolidative pneumonia (28.8% vs 17.2%, P = .004), hospitalization (83.2% vs 70%, P = .003), ICU admission (7.2% vs 3.0%, P = .034), and length of stay (median [IQR], 9 days [2–16] vs 5 days [0–12]; P = .002). Mortality rates at day 30 were comparable (9.6% vs 9.7%, P = .973). Conclusions This study included the largest cohort of patients infected with RSV aged >75 years documented in-depth thus far. RSV shares a comparable mortality rate with influenza but is associated with higher rates of consolidative pneumonia, hospitalization, ICU admissions, and extended hospital stays.
Source PubMed · Recherche par auteur (homonymes possibles, vérifier l'affiliation).
Communications medicine · 2026 · Journal Article
Bay P, Boizeau L, Préau S, Favory R, et al.
Diagnostic microbiology and infectious disease · 2026 · Journal Article
Rosse D, Garrigou O, Ortonne V, Ingiliz P, et al.
Diagnostic microbiology and infectious disease · 2025 · Journal Article
Vo-Quang E, Rosse D, Ortonne V, Garrigou O, et al.
Gut · 2024 · Journal Article
Vo-Quang E, Pawlotsky JM
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2024 · Journal Article
Rezzoug I, Emeraud C, Rodriguez C, Pawlotsky JM, et al.
Journal of medical virology · 2023 · Journal Article
Bay P, Rodriguez C, Caruso S, Demontant V, et al.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2023 · Journal Article
Emeraud C, Mahamat A, Jousset AB, Bernabeu S, et al.
Hepatology (Baltimore, Md.) · 2023 · Journal Article
Vo-Quang E, Soulier A, Ndebi M, Rodriguez C, et al.
Journal of hepatology · 2023 · Letter
Rodriguez C, Marchand S, Sessa A, Cappy P, et al.
Emerging infectious diseases · 2023 · Journal Article
Rodriguez C, Boizeau L, Soulier A, N'Debi M, et al.
The lancet. Gastroenterology & hepatology · 2023 · Journal Article
Pawlotsky JM
Scientific reports · 2022 · Journal Article
Morin-Dewaele M, Bartier S, Berry F, Brillet R, et al.
Infectious diseases and therapy · 2026 · Journal Article
Audureau E, Bay P, Préau S, Favory R, et al.
Intensive care medicine experimental · 2025 · Journal Article
Bruel T, Staropoli I, Bay P, Bastard P, et al.
Annals of intensive care · 2024 · Journal Article
de Prost N, Audureau E, Guillon A, Handala L, et al.
The Journal of infectious diseases · 2025 · Journal Article
Caillault A, Softic L, Bay P, Ly A, et al.
The Journal of infectious diseases · 2024 · Journal Article
Recto CG, Fourati S, Khellaf M, Pawlotsky JM, et al.
The Lancet. Public health · 2023 · Journal Article
Pawlotsky JM
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2024 · Journal Article
Boyd A, El Dani M, Ajrouche R, Demontant V, et al.
The Journal of infectious diseases · 2022 · Journal Article
Catlett B, Hajarizadeh B, Cunningham E, Wolfson-Stofko B, et al.
The Journal of infectious diseases · 2022 · Journal Article
Catlett B, Hajarizadeh B, Cunningham E, Wolfson-Stofko B, et al.
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron sublineage JN.1 in critically ill COVID-19 patients: a prospective, multicenter cohort study in France, November 2022 to January 2024
Abstract Background A notable increase in severe cases of COVID-19, with significant hospitalizations due to the emergence and spread of JN.1 was observed worldwide in late 2023 and early 2024. However, no clinical data
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron sublineage JN.1 in critically ill COVID-19 patients: a prospective, multicenter cohort study in France, November 2022 to January 2024
Abstract Background A notable increase in severe cases of COVID-19, with significant hospitalizations due to the emergence and spread of JN.1 was observed worldwide in late 2023 and early 2024. However, no clinical data
Additional file 1 of COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants
Additional file 1: Figure S1. Diagnosis criteria of CAPA (proven/probable and possible), relied on ECMM/ISHAM consensus criteria. BAL, bronchoalveolar lavage; CAPA, COVID-19-associated pulmonary aspergillosis; PCR, polym
Clinical phenotypes and outcomes associated with SARS-CoV-2 Omicron variants BA.2, BA.5 and BQ.1.1 in critically ill patients with COVID-19: a prospective, multicenter cohort study
Abstract Background Despite current broad natural and vaccine-induced protection, a substantial number of patients infected with emerging SARS-CoV-2 variants (e.g., BF.7 and BQ.1.1) still experience severe COVID-19. Real
Impaired serum neutralization and death in Omicron-infected critically ill patients: insights from the French SEVARVIR prospective, multicenter cohort study
Abstract Background Despite advances in treatment, critically ill COVID-19 patients requiring intensive care unit (ICU) admission continue to comprise a substantial proportion of cases. However, the factors influencing p
Impaired serum neutralization and death in Omicron-infected critically ill patients: insights from the French SEVARVIR prospective, multicenter cohort study
Abstract Background Despite advances in treatment, critically ill COVID-19 patients requiring intensive care unit (ICU) admission continue to comprise a substantial proportion of cases. However, the factors influencing p
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).
Intensive care medicine experimental · 2023 · Journal Article
de Prost N, Audureau E, Préau S, Favory R, et al.